Quetiapine, sold under the brand name Seroquel, carries a real but relatively uncommon risk of seizures at prescribed doses. Large pharmacovigilance studies place the seizure rate for second-generation antipsychotics as a class at roughly 0.05% of treated patients, and quetiapine falls squarely in that range. The risk climbs sharply in overdose, where seizures become a recognized and sometimes delayed complication. What makes the quetiapine-seizure relationship worth understanding is not just the baseline risk but the situations that amplify it: drug interactions, withdrawal, pre-existing epilepsy, and the formulation sitting in your medicine cabinet.
How Often Seizures Happen at Normal Doses
At therapeutic doses, quetiapine-related seizures are uncommon. A large drug-safety surveillance project tracking antipsychotic-related seizures found that tonic-clonic seizures occurred in about 0.05% of patients taking second-generation antipsychotics, a rate shared by quetiapine’s drug class and only slightly above the roughly 0.03% seen with older antipsychotics like haloperidol.1PubMed. Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project Broader reviews of the literature put the seizure incidence for most commonly used antipsychotics and antidepressants at therapeutic doses somewhere between 0.1% and 1.5%, compared to a background rate of unprovoked first seizures in the general population of about 0.07% to 0.09%.2PubMed Central. Effects of psychotropic drugs on seizure threshold So the risk is real and measurably above baseline, but for most people on a standard dose, it remains small.
That said, case reports show seizures can appear even in patients who have been on quetiapine for a long time without trouble. One published case involved a 75-year-old man with Alzheimer’s disease who had been taking quetiapine 500 mg daily for 18 months before experiencing seizures. No other metabolic, toxic, or structural explanation was found, and after quetiapine was stopped, the seizures did not return.3PubMed. Seizures associated with quetiapine treatment Cases like that are a reminder that the risk is not limited to the first few weeks of treatment.
How Quetiapine Compares to Other Antipsychotics
Among antipsychotics, clozapine is the clear outlier for seizure risk, and quetiapine sits in a middle tier. A disproportionality analysis of the FDA’s adverse event reporting database found that ziprasidone had the strongest seizure signal among atypical antipsychotics, followed by quetiapine, clozapine, olanzapine, and aripiprazole. Risperidone, paliperidone, and lurasidone had comparatively weaker signals.4PubMed Central. Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS) A separate pharmacovigilance study found that second-generation antipsychotics as a group were associated with a higher reporting odds of convulsions compared to first-generation drugs, with the reporting odds ratio remaining elevated even after removing clozapine from the calculation.5PubMed Central. Antipsychotics and seizures: higher risk with atypicals?
These numbers deserve a caveat. Adverse event reporting databases capture signals from voluntary reports, not controlled trials, so they reflect what gets reported rather than what happens in a perfectly tracked population. Quetiapine is one of the most widely prescribed antipsychotics in the world, and its extensive use for off-label purposes like insomnia means more people are taking it, which means more adverse events get reported regardless of whether the per-patient risk is truly higher. Still, the consistent signal across multiple data sources suggests the risk is not just an artifact of popularity.
The Overdose Problem
Seizure risk with quetiapine changes dramatically in overdose. Broader reviews estimate seizure rates of roughly 4% to 30% in antipsychotic overdose, a steep jump from the fraction-of-a-percent rates seen at therapeutic doses.6PubMed Central. Effects of psychotropic drugs on seizure threshold In data from intentional recreational quetiapine abuse cases tracked through poison control, about 0.8% of cases with known outcomes involved seizures, a figure that likely underestimates the risk in large intentional overdoses because the abuse cohort includes many smaller ingestions.7PubMed Central. Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics
What catches clinicians off guard is timing. A case report documented a generalized tonic-clonic seizure occurring 28 hours after ingestion of just 1,400 mg of quetiapine, a dose considered relatively low for an overdose. The patient had no obvious signs of severe toxicity beforehand, yet the seizure appeared well over a day later.8PubMed Central. Delayed-Onset Seizure in a Mild Quetiapine Overdose: Report of a Case and Review of the Literature Delayed-onset seizures have been identified as a genuine pattern in quetiapine overdose, which means a patient who seems stable in the emergency department hours after ingestion is not necessarily out of the woods. This is a meaningful clinical consideration: premature discharge after an apparent quetiapine overdose recovery can leave a person at home when a seizure hits.
Extended-Release Versus Immediate-Release Formulations
Seroquel comes in two forms: immediate-release (IR) and extended-release (XR). In overdose, these behave quite differently. A study comparing the two formulations in overdose patients found that XR quetiapine was associated with substantially delayed toxicity. The time to lowest consciousness level was about 7 hours for the extended-release form compared to roughly 4 hours for immediate-release. Recovery from sedation took a median of 20 hours with XR versus 12 hours with IR. Among patients who needed intubation, the median duration was 47 hours for XR compared to 17 hours for IR.9PubMed Central. Extended-release quetiapine overdose is associated with delayed onset of toxicity compared to immediate-release quetiapine overdose
The implication for seizure risk follows logically: if the drug’s peak effects arrive later and last longer with the XR formulation, then the window of vulnerability for seizures extends further too. This matters for anyone involved in monitoring after an overdose. Observation periods that might be adequate for immediate-release quetiapine may not be long enough for the extended-release version.
Drug Interactions That Change the Equation
Quetiapine is broken down primarily by a liver enzyme called CYP3A4, and drugs that speed up or slow down that enzyme can shift quetiapine levels in ways that matter for seizure risk. Several common antiepileptic drugs, including carbamazepine, phenytoin, and phenobarbital, rev up CYP3A4 activity and can dramatically lower quetiapine blood levels. One study found that adding phenytoin to a quetiapine regimen increased quetiapine clearance more than fivefold.10PubMed Central. Important drug interaction involving phenytoin and quetiapine Valproate and other antiepileptic drugs can similarly reduce quetiapine concentrations.11PubMed. Clinically significant drug interactions with atypical antipsychotics
This creates a tricky situation for patients who take quetiapine alongside seizure medications. If the antiepileptic drug is clearing quetiapine out of the body faster, the quetiapine may not reach effective levels for its psychiatric purpose. A prescriber might respond by raising the quetiapine dose. But if the antiepileptic is later stopped or swapped for a drug that does not induce CYP3A4, quetiapine levels could suddenly spike, potentially pushing the patient into a range where seizure risk increases. The interaction works in both directions and requires careful monitoring whenever anti-seizure medications are started, stopped, or changed.
Conversely, drugs that inhibit CYP3A4, such as certain antifungals and some antibiotics, can raise quetiapine levels above what the prescribed dose would normally produce. This is less commonly discussed in the seizure context, but it follows the same logic: unexpectedly high drug levels increase the chance of dose-dependent side effects.
What EEG Studies Show
Even when seizures do not occur, antipsychotics can produce abnormal electrical patterns on an electroencephalogram (EEG). These changes do not necessarily predict clinical seizures, but they are a marker of how much a drug is irritating the brain’s electrical activity. In this domain, quetiapine looks relatively benign. One study comparing EEGs across patients on quetiapine, olanzapine, and haloperidol found that only about 5% of quetiapine-treated patients had an abnormal EEG, comparable to healthy controls at 7%. By contrast, 35% of olanzapine patients and 23% of haloperidol patients had abnormalities, and frank epileptiform activity appeared in 11% of the olanzapine group but in none of the quetiapine patients.12PubMed. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects
A second study looking at EEGs under strict antipsychotic monotherapy told a slightly different story. Sharp or epileptiform activity was found in about 37.5% of quetiapine patients compared to a striking 91% for clozapine. But quetiapine’s rate was not dramatically different from olanzapine (about 59%) or risperidone (about 44%).13PubMed. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies Interestingly, the EEG changes with quetiapine were associated with lower doses rather than higher ones, which is counterintuitive and not fully explained. These two studies had very different sample sizes and methodologies, so the gap between their findings is not surprising. The takeaway is that quetiapine generally produces fewer EEG disturbances than clozapine or olanzapine, but it is not entirely electrically neutral.
Quetiapine in People Who Already Have Epilepsy
For people with epilepsy who develop psychotic symptoms or other psychiatric conditions requiring an antipsychotic, the choice of medication takes on extra weight. Quetiapine is sometimes used in this population, though the evidence base is thin. A review of antipsychotic use in epilepsy patients found that olanzapine and quetiapine appear to carry some seizure risk, though less than clozapine, while risperidone showed no difference from placebo.14PubMed Central. Treatment of psychoses in patients with epilepsy: an update This does not mean quetiapine is off-limits for people with epilepsy, but it does mean the prescriber is balancing the psychiatric benefit against a non-trivial possibility of worsening seizure control.
There is also a practical complication here: the drug interactions described earlier. Many epilepsy patients are already on medications like carbamazepine or phenytoin that slash quetiapine levels. Getting the dose right requires measuring blood levels more carefully than in a patient on quetiapine alone, and any change to the anticonvulsant regimen can destabilize the whole balance.
Younger Patients and Unexpected Reactions
Quetiapine is prescribed to adolescents for conditions like bipolar disorder and schizophrenia, and seizure-related events have been reported even at low doses in younger patients. One case involved a 16-year-old with bipolar disorder who developed hypotension and convulsive syncope after a small dose of quetiapine.15PubMed Central. Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder Convulsive syncope, a fainting episode that triggers brief seizure-like movements due to temporary loss of blood flow to the brain, is different from a true epileptic seizure but can look identical to a bystander. Quetiapine’s tendency to lower blood pressure, especially when first started or when doses change, can set up this kind of event. For parents and clinicians, the distinction matters because the management is different: treating hypotension rather than reaching for an antiepileptic drug.
This raises a broader point. Not every seizure-like event on quetiapine is a drug-induced epileptic seizure. Quetiapine can cause significant drops in blood pressure, especially on standing, and those drops can trigger fainting with convulsive movements. Sorting out the cause requires an EEG and sometimes other workup, because the treatment paths diverge depending on whether the brain is producing epileptic discharges or simply lost blood flow for a few seconds.
What Happens When Quetiapine Is Stopped
Abruptly stopping quetiapine can produce a withdrawal syndrome. A systematic review of quetiapine withdrawal found an association between rapid cessation and a range of symptoms including nausea, vomiting, agitation, restlessness, sweating, irritability, anxiety, insomnia, rapid heart rate, high blood pressure, and dizziness.16PubMed. Quetiapine withdrawal: A systematic review Seizures were not among the commonly reported withdrawal symptoms in that review, but the overall picture of neurological hyperexcitability after abrupt discontinuation is one that, in theory, could lower the seizure threshold in someone already vulnerable.
The evidence here is limited. The review itself noted that all included studies were individual case reports and that the quality was sub-optimal. Still, the general principle holds: tapering quetiapine gradually rather than stopping it cold is standard practice partly because the rebound excitability that comes with sudden withdrawal is unpredictable. If you have a history of seizures, this is doubly important to discuss with your prescriber before making any changes to your dose.
Recreational Misuse and Seizure Reports
Quetiapine has an unusual reputation among antipsychotics for recreational misuse, sometimes called “quell” or “Suzy-Q” on the street. It is sought out for its sedating effects, and it circulates in correctional facilities and shelters. Among poison-control data on intentional recreational quetiapine abuse, about 0.8% of cases with known outcomes involved seizures, alongside other serious effects like hypotension and respiratory depression.17PubMed Central. Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics The combination of quetiapine with other substances, particularly alcohol or benzodiazepines, can produce unpredictable effects on consciousness and seizure threshold. In these settings, the drug interactions are uncontrolled and the doses are often unknown, making the seizure risk harder to quantify but likely elevated above what clinical data would suggest.
Practical Considerations for People on Quetiapine
If you are taking quetiapine and have never had a seizure, your risk of having one from the medication is small but not zero. A few situations raise the risk enough to be worth knowing about:
- High doses: Seizure risk with antipsychotics generally scales with dose. Keeping to the lowest effective dose reduces risk across the board.
- Medication changes: Starting or stopping drugs that interact with CYP3A4 can shift quetiapine blood levels significantly. If your prescriber adds or removes a medication, ask whether it could affect your quetiapine level.
- Abrupt discontinuation: Stopping quetiapine suddenly rather than tapering introduces a period of neurological rebound that could increase vulnerability.
- Overdose, intentional or accidental: Seizure risk rises steeply with supratherapeutic doses, and with extended-release formulations the danger can be delayed by many hours.
- Pre-existing seizure history: If you have epilepsy or have had seizures from other causes, the risk from quetiapine is additive. Your prescriber may prefer a different antipsychotic like risperidone, which has not shown elevated seizure risk compared to placebo in epilepsy patients.
For people who experience a first seizure while on quetiapine, the workup should not assume the drug is responsible without ruling out other causes. But as the case report of the 75-year-old patient demonstrated, when no other explanation is found and seizures stop after discontinuation, quetiapine moves to the top of the suspect list.18PubMed. Seizures associated with quetiapine treatment In those situations, switching to an antipsychotic with a cleaner seizure profile is the standard approach.
Why the Research Remains Patchy
One frustration with this topic is how thin the direct evidence is. Much of what we know about quetiapine and seizures comes from adverse event databases, case reports, and pharmacovigilance projects rather than prospective controlled studies specifically designed to measure seizure rates. No pharmaceutical company has an incentive to run a trial asking “how often does our drug cause seizures?” and ethics committees would not approve giving quetiapine to healthy volunteers to find out. So the data accumulates piecemeal, one case at a time and one database query at a time, and the estimates carry more uncertainty than clinicians or patients would like. The FAERS database analysis, for instance, shows quetiapine with a notable seizure signal, but reporting odds ratios from voluntary reports can be inflated by awareness bias: once clinicians learn a drug might cause seizures, they are more likely to report seizure events associated with it.
What the available evidence does consistently show is that quetiapine occupies a middle position among antipsychotics for seizure risk. It is not as clean as risperidone or paliperidone, not as concerning as clozapine, and roughly in line with olanzapine depending on which data source you consult. For someone who needs an antipsychotic, that middle-tier position is usually manageable. For someone with specific risk factors, it is worth a careful conversation about alternatives.